CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Baxter International Inc   (BAX)
Other Ticker:  
 


Baxter International Inc 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Baxter International Inc 's ROA in the second quarter of 2024?
Baxter International Inc achieved a return on average assets (ROA) of 8.96 % in its second quarter of 2024, this is above BAX's average return on assets of 8.88%.
Baxter International Inc s assets during the 12 months ending in the second quarter of 2024 are valued at $27 billion

ROA decreased relative to the period ending Mar 31 2024, due to the decline in net income.

However, within the Healthcare sector 69 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2024 quarter, so far to 548, from total ROA ranking in the first quarter of 2024 at 554.

What is ROA?


Return On Assets (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Total Assets Change -5.72 % -1.73 % 0.05 % 9.91 % -12.52 %
Y / Y Net Income Change - -13.33 % 32.97 % - -
Net Income (TTM) in million 2,485 2,657 2,663 2,602 -2,843
Return On Assets (TTM) 8.96 % 9.45 % 9.43 % 9.21 % -10.32 %
BAX's Total Ranking # 548 # 554 # 634 # 669 # 3427
Total Assets (TTM) in million 25,788 27,257 27,752 30,137 27,352
Seq. Total Assets Change -5.39 % -1.78 % -7.91 % 10.18 % -1.39 %
Seq. Net Income Change - -84.15 % -90.2 % - -

BAX's 5 Years Annual ROA >> Back to BAX Management Effectiveness >> Compare BAX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 22
Sector # 70
Overall # 547

Return On Assets Statistics
High Average Low
30.71 %
8.88 %
-10.11 %
(Dec 31 2016)   (Jun 30 2023)





Financial Statements
Baxter International Inc 's Assets $ 25,788 million BAX's Balance sheet
Baxter International Inc 's Income $ -311 million Quarterly BAX's Income Statement
BAX's Income by Division See BAX's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change 0.05 % -15.67 % 69.4 % 6.72 % 16.32 %
Total Assets in million 27,752 27,737 32,891 19,416 18,193
Y / Y Net Income Change - - 16.67 % 9.79 % -37.75 %
Net Income in million 2,663 -2,421 1,295 1,110 1,011
Return On Assets 9.6 % -8.73 % 3.94 % 5.72 % 5.56 %

BAX's 5 Years Annual ROA >> Back to BAX Management Effectiveness >> Compare BAX ROA to its Competitors



Comment on BAX's ROA in the fiscal year ending 2023
In the fiscal year 2023 ROA improved to 9.6 % compared to prior year, due to annual net income growth of % to $2,663.00 million, while value of Baxter International Inc 's overall assets grew just by 0.05 % to $27,752.00 million, compared to $27,752.00 a year before.


More Return On Assets Ratios
BAX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BAX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for BAX's Competitors
Roa for Baxter International Inc 's Suppliers
Return On Assets for BAX's Customers

You may also want to know
BAX's Roi BAX's Inventory Turnover Ratio BAX's Growth Rates BAX's Dividend Comparisons
BAX's Profitability Ratios BAX's Asset Turnover Ratio BAX's Dividend Growth
BAX's Roe BAX's Valuation Ratios BAX's Financial Strength Ratios BAX's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector ROA
National Research Corporation  24.26 %
Mettler Toledo International Inc  23.85 %
Johnson and Johnson  22.15 %
Iradimed Corporation  21.09 %
Carlisle Companies Incorporated  19.95 %
Medpace Holdings Inc   19.81 %
Semler Scientific inc   19.40 %
Corcept Therapeutics Inc  19.33 %
Tg Therapeutics Inc   18.84 %
Halozyme Therapeutics Inc   18.14 %
Chemed Corporation  17.98 %
Zoetis Inc   16.46 %
Cassava Sciences Inc  15.71 %
United Therapeutics Corporation  15.61 %
Alpha Pro Tech Ltd   15.35 %
Edwards Lifesciences Corporation  15.24 %
Insulet Corporation  14.97 %
Resmed Inc   14.94 %
Kewaunee Scientific Corporation  14.59 %
Zura Bio Limited  14.43 %
West Pharmaceutical Services Inc   14.31 %
Prestige Consumer Healthcare Inc   14.16 %
Harmony Biosciences Holdings inc   13.96 %
Intuitive Surgical Inc   13.47 %
Regeneron Pharmaceuticals Inc   12.74 %
Merck and Co Inc   12.74 %
Krystal Biotech Inc   12.54 %
Msa Safety Inc  12.39 %
Tenet Healthcare Corp  12.39 %
Ufp Technologies Inc   12.13 %

Date modified: 2024-08-07T19:52:45+00:00


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com